Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of dapaglifloziN Therapy on Myocardial Perfusion Reserve in Prediabetic Patients With Stable coronarY Artery Disease (ENTRY Trial)

NCT04330079 is registered in ClinicalTrials.gov with CHEOL WHAN LEE, M.D., Ph.D as lead sponsor.

NCT NCT04330079
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04330079 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of dapaglifloziN Therapy on Myocardial Perfusion Reserve in Prediabetic Patients With Stable coronarY Artery Disease (ENTRY Trial)
Lead sponsor
CHEOL WHAN LEE, M.D., Ph.D
Phase
Phase 4
Overall status
Terminated
Start date
May 21, 2020
Completion date
April 8, 2021
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, prediabetic state